Fulgent Genetics, Inc.
FLGT
$18.50
$0.191.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -115.32% | -297.72% | 54.89% | -117.65% | 14.35% |
| Total Depreciation and Amortization | 1.37% | -1.29% | 1.99% | -1.61% | -11.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.47% | 27.53% | -51.01% | 125.45% | 19.81% |
| Change in Net Operating Assets | 271.17% | -542.98% | 109.26% | -1,391.17% | -299.49% |
| Cash from Operations | 260.17% | -412.35% | 171.62% | -804.11% | -160.98% |
| Capital Expenditure | -10.26% | -31.82% | 69.03% | 47.27% | -16.32% |
| Sale of Property, Plant, and Equipment | 300.00% | -- | -92.11% | -100.00% | -99.22% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 120.99% | 168.14% | -25.02% | 197.71% | 174.78% |
| Cash from Investing | -60.55% | 140.63% | 112.40% | 631.16% | 158.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 6.93% | 35.29% | 35.29% | 85.38% | 32.67% |
| Issuance of Common Stock | -- | -98.04% | -- | -- | -- |
| Repurchase of Common Stock | -319.06% | -84.71% | 17.17% | -368.75% | -454.06% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -301.30% | -63.30% | 21.52% | -130.19% | -298.00% |
| Foreign Exchange rate Adjustments | -72.73% | 155.97% | -90.45% | 144.44% | 115.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -320.76% | -2,227.40% | 529.20% | 97.42% | 128.36% |